NCT05465668View on ClinicalTrials.gov

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

July 22, 2022

Primary Completion Date

August 16, 2022

Study Completion Date

November 22, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

DWP16001 Drug A

DWP16001 Drug A

DRUG

DWP16001 Drug C

DWP16001 Drug C

Trial Locations (1)

Unknown

CHA unuversity bundang medical center, Seongnam

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY